Delivery Order SPE2DB22D2206-SPE2DB23FKB03
Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a $8,000 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 mg vials of ABRAXANE, to be delivered to their Conshohocken, Pennsylvania location by July 27, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor to supply the chemotherapy drug to the Defense Logistics Agency under this single award. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $17,782 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication used in cancer treatment. This firm fixed price contract, awarded November 10, 2025, with completion by November 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award required no set-aside designation and was competitively awarded through open...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Abraxane 100 mg vials, a chemotherapy medication used in cancer treatment. This firm fixed-price delivery order, valued at $8,436.70 with an ultimate completion date of June 25, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $8,853.94 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abraxane 100 mg vials, with an ultimate completion date of August 27, 2025. This contract employs firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $8,741.22 to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with performance completion scheduled for September 17, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Abraxane 100 mg vials valued at $7,565.23. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventeen thousand eight hundred fifty-one dollars to Amerisourcebergen Drug Corporation for the delivery of one hundred milligram vials of Abraxane. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the prime contractor, Amerisourcebergen Drug Corporation located in Conshohocken, Pennsylvania, to provide one hundred milligram vials of Abraxane to support...
- This is a $11,248.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ABRAXANE 100 MG VIALS. The contract has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with a ceiling value of $3,781.37. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...